How do you select immunosuppression versus antifibrotic monotherapy in CTD-ILD with predominantly fibrotic physiology and minimal extrapulmonary activity?

What is your initial approach to CTD-ILD with predominantly fibrotic physiology and minimal extrapulmonary activity?

• Immunosuppression alone
• Antifibrotic monotherapy
• Immunosuppression plus an antifibrotic
• Monitor without drug therapy
• Other